JP2024518060A - 高脂血症を治療するための薬物組成物及びその調製方法 - Google Patents

高脂血症を治療するための薬物組成物及びその調製方法 Download PDF

Info

Publication number
JP2024518060A
JP2024518060A JP2023568628A JP2023568628A JP2024518060A JP 2024518060 A JP2024518060 A JP 2024518060A JP 2023568628 A JP2023568628 A JP 2023568628A JP 2023568628 A JP2023568628 A JP 2023568628A JP 2024518060 A JP2024518060 A JP 2024518060A
Authority
JP
Japan
Prior art keywords
vitamin
trace elements
treating hyperlipidemia
chlorogenic acid
vitamins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023568628A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024518060A5 (https=
Inventor
ジエ ジャン
ウェンビン リー
ワン ホアン
フェイ ジャン
ヤー ジャン
ミン シュー
Original Assignee
スーチョアン チウチャン バイオロジカル サイエンス アンド テクノロジー カンパニー リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by スーチョアン チウチャン バイオロジカル サイエンス アンド テクノロジー カンパニー リミテッド filed Critical スーチョアン チウチャン バイオロジカル サイエンス アンド テクノロジー カンパニー リミテッド
Publication of JP2024518060A publication Critical patent/JP2024518060A/ja
Publication of JP2024518060A5 publication Critical patent/JP2024518060A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4415—Pyridoxine, i.e. Vitamin B6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/32—Manganese; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/34—Copper; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2023568628A 2021-05-11 2022-05-09 高脂血症を治療するための薬物組成物及びその調製方法 Pending JP2024518060A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN202110509462.6 2021-05-11
CN202110509462.6A CN113143962B (zh) 2021-05-11 2021-05-11 一种治疗高脂血症的药物组合物及其制备方法
PCT/CN2022/091766 WO2022237731A1 (zh) 2021-05-11 2022-05-09 一种治疗高脂血症的药物组合物及其制备方法

Publications (2)

Publication Number Publication Date
JP2024518060A true JP2024518060A (ja) 2024-04-24
JP2024518060A5 JP2024518060A5 (https=) 2025-03-27

Family

ID=76874714

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023568628A Pending JP2024518060A (ja) 2021-05-11 2022-05-09 高脂血症を治療するための薬物組成物及びその調製方法

Country Status (5)

Country Link
US (1) US20240197665A1 (https=)
JP (1) JP2024518060A (https=)
KR (1) KR20230145464A (https=)
CN (1) CN113143962B (https=)
WO (1) WO2022237731A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113143962B (zh) * 2021-05-11 2022-08-05 四川九章生物科技有限公司 一种治疗高脂血症的药物组合物及其制备方法

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6041611A (ja) * 1983-08-17 1985-03-05 Sankyo Co Ltd 血中脂質低下剤
JP2002308766A (ja) * 2001-04-13 2002-10-23 Kao Corp 生活習慣病予防・改善剤
JP2003034636A (ja) * 2001-07-19 2003-02-07 Kao Corp 脂質代謝改善剤
US7332181B1 (en) * 2003-09-05 2008-02-19 Glu-Pro, Inc. Composition for managing diabetes, obesity, and hyperlipidemia and associated methods
US20120034323A1 (en) * 2010-08-03 2012-02-09 Northern Innovations And Formulations Corp. Compositions and methods for promoting weight loss and increasing energy
JP2017537092A (ja) * 2014-11-24 2017-12-14 スーチョアン チウチャン バイオロジカル サイエンス アンド テクノロジー カンパニー リミテッド クロロゲン酸結晶形を含む製剤およびその用途
CN110141581A (zh) * 2019-05-29 2019-08-20 山东腾贵医药有限公司 一种辅助治疗三高的维生素矿物质营养组合物及其制备方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000015215A1 (en) * 1998-09-15 2000-03-23 Korea Research Institute Of Bioscience And Biotechnology Composition containing cinnamic acid derivatives for preventing or treating elevated blood lipid level-related diseases
US20020193323A1 (en) * 2000-11-22 2002-12-19 Inna Yegorova Compositions and methods for promoting a healthy cardiovascular system and enhancing blood flow
US6632459B2 (en) * 2000-12-11 2003-10-14 Nutricia N.V. Chlorogenic acid and an analog thereof for immune system stimulation
US6592896B2 (en) * 2001-08-06 2003-07-15 The Quigley Corporation Medicinal composition and method of using it
JP2006104182A (ja) * 2004-05-14 2006-04-20 Toyo Shinyaku:Kk 体脂肪低減組成物
US20080286254A1 (en) * 2007-05-17 2008-11-20 Kaneka Corporation Composition comprising licorice polyphenol
CN101766274B (zh) * 2010-01-05 2012-10-31 杭州尤美特科技有限公司 含竹叶黄酮的抗氧化功能食品组合物
EP3040067A4 (en) * 2013-08-21 2017-03-22 Sichuan Jiuzhang Biological Science And Technology Co., Ltd Chlorogenic acid powder-injection and preparation method thereof
DE102014100534A1 (de) * 2014-01-17 2015-07-23 Pm-International Ag Pulverförmige Zusammensetzung zur Herstellung eines Nahrungsmittelersatzes
US20150335604A1 (en) * 2014-05-22 2015-11-26 Boresha International Chromium and Chlorogenic Acid Weight Control Formulations
IL282156B (en) * 2014-07-29 2022-07-01 Shenzhen Hightide Biopharmaceutical Ltd Berberine salts, ursodeoxycholic salts and combinations, methods of preparation and application thereof
US20180235917A1 (en) * 2014-09-24 2018-08-23 Nusirt Sciences, Inc. Compositions, methods and kits for treatment of diabetes and/or hyperlipidemia
CN104739818A (zh) * 2015-02-13 2015-07-01 四川九章生物科技有限公司 绿原酸在制备治疗病理性黄疸的药物中的用途
JP2020519688A (ja) * 2017-05-12 2020-07-02 ハウジー ファーマシューティカル リサーチ ラボラトリーズ、エル．エル．シー． 抗糖尿病活性および他の有用な活性を有する植物抽出物
CN107661409A (zh) * 2017-11-25 2018-02-06 衡阳县华盛达农林科技有限公司 一种治疗心脑血管疾病的芦丁口服液及其制备方法
CN108208838A (zh) * 2018-03-09 2018-06-29 北京素维生物科技有限公司 一种掩味组合物及其用途
CN110448659A (zh) * 2018-05-07 2019-11-15 新疆吉盛元沙棘生物科技有限公司 沙棘护肝含片制备方法
CN108498497B (zh) * 2018-06-01 2020-05-01 四川九章生物科技有限公司 用于治疗肾癌的药物组合物及其应用
CN111195298B (zh) * 2020-02-17 2021-12-24 集美大学 一种调节肠道菌群和防治食物过敏的组合物及其制备方法
CN112341355B (zh) * 2020-11-09 2022-08-30 中国医学科学院药用植物研究所 一种绿原酸衍生物及其制备方法和应用
CN113143962B (zh) * 2021-05-11 2022-08-05 四川九章生物科技有限公司 一种治疗高脂血症的药物组合物及其制备方法

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6041611A (ja) * 1983-08-17 1985-03-05 Sankyo Co Ltd 血中脂質低下剤
JP2002308766A (ja) * 2001-04-13 2002-10-23 Kao Corp 生活習慣病予防・改善剤
JP2003034636A (ja) * 2001-07-19 2003-02-07 Kao Corp 脂質代謝改善剤
US7332181B1 (en) * 2003-09-05 2008-02-19 Glu-Pro, Inc. Composition for managing diabetes, obesity, and hyperlipidemia and associated methods
US20120034323A1 (en) * 2010-08-03 2012-02-09 Northern Innovations And Formulations Corp. Compositions and methods for promoting weight loss and increasing energy
JP2017537092A (ja) * 2014-11-24 2017-12-14 スーチョアン チウチャン バイオロジカル サイエンス アンド テクノロジー カンパニー リミテッド クロロゲン酸結晶形を含む製剤およびその用途
CN110141581A (zh) * 2019-05-29 2019-08-20 山东腾贵医药有限公司 一种辅助治疗三高的维生素矿物质营养组合物及其制备方法

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
RODRIGUEZ DE SOTILLO, DELCY V ET AL.: ""Chlorogenic acid modifies plasma and liver concentrations of: cholesterol, triacylglycerol, and mi", THE JOURNAL OF NUTRITIONAL BIOCHEMISTRY, vol. 13, no. 12, JPN6026008912, December 2002 (2002-12-01), pages 717 - 726, ISSN: 0005813236 *
SANTANA-GLVEZ, JESS ET AL.: ""Chlorogenic Acid: Recent Advances on Its Dual Role as a Food Additive and a Nutraceutical against", MOLECULES, vol. 22, no. 3, JPN6026008915, 26 February 2017 (2017-02-26), pages 358, ISSN: 0005813237 *
臼井朋包: ""食品中に含まれる微量金属量の測定 : −Se, Mn, Cu, Zn, Alについて−"", 食物学会誌, vol. 46, JPN6026008911, 1991, pages 26 - 46, ISSN: 0005813235 *

Also Published As

Publication number Publication date
CN113143962A (zh) 2021-07-23
US20240197665A1 (en) 2024-06-20
CN113143962B (zh) 2022-08-05
WO2022237731A1 (zh) 2022-11-17
KR20230145464A (ko) 2023-10-17

Similar Documents

Publication Publication Date Title
US20220265682A1 (en) Drug composition containing abiraterone acetate, and preparation method therefor and application thereof
CN101309688B (zh) 持续释放β-丙氨酸的组合物和方法
CN1956734A (zh) 复合维生素和矿物质的营养补充剂
ES2861023T3 (es) Composición reductora de grasa en la sangre y aplicación de la misma
CN100418548C (zh) 一种药用组合物及其用途
JP2024518060A (ja) 高脂血症を治療するための薬物組成物及びその調製方法
CN110538315A (zh) 一种具有防治透析患者并发症功效的组合物及其制备方法和其应用
CN101912407B (zh) 一种减肥降脂组合物
WO2020063262A1 (en) Application of 3'-deoxyinosine in preparation of drug, food or health product for multiple disease
CN104840480B (zh) 二甲双胍/叶酸/维生素b12药物组合物的新用途
WO2020020317A1 (zh) 二甲双胍复配组合物及其应用
RU2436415C2 (ru) Композиция биологически активных веществ на основе бетулина с регулируемой скоростью высвобождения компонентов для снижения степени алкогольного опьянения, предупреждения и снятия алкогольной интоксикации и похмельного синдрома
CN106924270A (zh) 一种含有奥利司他的具有减肥功能的药物组合物
CN108323762B (zh) 一种富硒组合物及制剂，其制备方法和应用
CN104721208B (zh) 一种预防和治疗脂肪肝及降血脂的药物制剂
CN100579567C (zh) 一种中药制剂在制备预防冠心病药物中的用途
CN108991358A (zh) 一种辅助降血脂、降血糖、缓解痛风保健食品及生产方法
CN121622687A (zh) 一种有助于维持血脂健康水平的维生素组合物
CN120982657A (zh) 一种用于宠物犬/猫降血脂作用的营养补充剂及其制备方法和用途
KR20170026241A (ko) 경구용 복합제제
CN121622713A (zh) 一种改善或延缓衰老的药物组合物
EP3037098B1 (en) Composition for the treatment and prevention of a disorder correlated with haematic cholesterol and /or hematic glycemia
CN121313723A (zh) 一种具有降血糖功效的天然山茶油
CN117016786A (zh) 具有降血脂功能的大豆卵磷脂片剂及其制备方法
CN118717997A (zh) 含有乙酰辅酶a羧化酶抑制剂的药物组合物及其用途

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250318

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20250318

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20260227

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20260310